Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Lotery AJ, Regnier S . Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the USA. Eye 2015; 29: 380–387.
Campochiaro PA, Sophie R, Pearlman J, Brown DM, Boyer DS, Heier JS et al. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab. The Retain study. Ophthalmology 2014; 121: 209–219.
Heier JS, Clark WL, Boyer DS, Brown DM, Vitti R, Berliner AJ et al. Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion. Two-year results from the Copernicus Study. Ophthalmology 2014; 121: 1414–1420.
Ogura Y, Roider J, Korobelnik JF, Holz FG, Simader C, Schmidt-Erfurth U et al. Intravitreal aflibercept for macular edema secondary to central retinal occlusion. 18-month results of the phase 3 Galileo study. Am J Ophthalmol 2014; 158: 1032–1038.
Călugăru D, Călugăru M . Intravitreal bevacizumab in acute central/hemicentral retinal vein occlusions: three-year results of a prospective clinical study. J Ocul Pharmacol Ther 2015; 31: 78–86.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Author contributions
Both authors (DC and MC) were involved in design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review or approval of the manuscript.
Rights and permissions
About this article
Cite this article
Călugăru, D., Călugăru, M. Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the USA. Eye 29, 1113 (2015). https://doi.org/10.1038/eye.2015.68
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2015.68
This article is cited by
-
Response to Comment on: Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA
Eye (2017)
-
Response to ‘Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the USA’
Eye (2015)
